2238 Palazzo, Juan P. - Thomas Jefferson University - Thomas Jefferson University

Juan P. Palazzo, MD

Contact Dr. Palazzo

132 South 10th Street
Room 285 Main Building
Philadelphia, PA 19107

(215) 955-6352
(215) 923-1969 fax

Most Recent Peer-reviewed Publications

  1. Erythropoiesis stimulating agents and clinical outcomes of invasive breast cancer patients receiving cytotoxic chemotherapy
  2. Postoperative hyperphosphatemia significantly associates with adverse survival in colorectal cancer patients
  3. Preoperative platelet count associates with survival and distant metastasis in surgically resected colorectal cancer patients
  4. Post-diagnosis hemoglobin change associates with overall survival of multiple malignancies - results from a 14-year hospital-based cohort of lung, breast, colorectal, and liver cancers
  5. Caloric restriction augments radiation efficacy in breast cancer
  6. Impact of oncotype DX on treatment decisions in ER-positive, node-negative breast cancer with histologic correlation
  7. Acinar Cell Cystadenoma of the Pancreas: Report of Three Cases and Literature Review
  8. A review of adenoid cystic carcinoma of the breast with emphasis on its molecular and genetic characteristics
  9. Boerhaave's syndrome as an initial presentation of eosinophilic esophagitis: A case series
  10. Adjuvant therapy in Stage i carcinoma of the breast: The influence of multigene analyses and molecular phenotyping
  11. Adjuvant therapy in stage i carcinoma of the breast: The influence of multigene analyses and molecular phenotyping
  12. Genetic polymorphism in a vegf-independent angiogenesis gene angpt1 and overall survival of colorectal cancer patients after surgical resection
  13. Dysplastic lesions in inflammatory bowel disease show increased positivity for the stem cell marker aldehyde dehydrogenase
  14. Genetic polymorphisms in pre-microRNA genes as prognostic markers of colorectal cancer
  15. AIRP best cases in radiologic-pathologic correlation: Spindle cell carcinoma of the esophagus
  16. IMP3, a proposed novel basal phenotype marker, is commonly overe 079B xpressed in adenoid cystic carcinomas but not in apocrine carcinomas of the breast
  17. Prognostic markers and long-term outcomes in ductal carcinoma in situ of the breast treated with excision alone
  18. Prognostic significance of high-grade dysplasia in colorectal adenomas
  19. Assessment of immunohistochemistry for p16ink4 and high-risk HPV DNA by in situ hybridization in esophageal squamous cell carcinoma
  20. Parametric imaging using subharmonic signals from ultrasound contrast agents in patients with breast lesions